摘要
目的表达大鼠γ-干扰素诱导蛋白-10(IP-10)融合蛋白,并测定其生物学活性。方法从大鼠脾细胞中提取总RNA,用RT-PCR方法得到IP-10cDNA,双酶切将其插入pET-32(a)+载体中。重组质粒pET-32a(+)-IP10经测序证实。将pET-32a(+)-IP10转化大肠杆菌BL21(DE3)中进行表达,目的蛋白经镍离子亲和层析柱纯化。微室跨膜迁移实验测定其生物学活性。结果测序表明,所构建的重组质粒pET-32a(+)-IP10序列完全正确,诱导表达的蛋白的相对分子量同预期分子量相同,微室跨膜迁移实验测定出IP-10融合蛋白对激活的T淋巴细胞具有良好的趋化活性。结论成功在大肠杆菌中表达了IP-10融合蛋白,并具有生物学活性。
【Objective】To express rat IFN-γ-inducible protein-10 (IP-10) fusion protein in E. coli. and analyze its biological activity.【Methods】Total RNA was isolated from rat spleen cells, and reverse transcription- PCR was performed based on the IP-10 nucleotide sequence, PCR products were cloned into the pET-32(a)+ vector after being digested by two restrictive enzymes of Kpn I and EcoR I. The sequence of recombinant plasmid pET-32a (+)-IP10 was verified by DNA sequencing, and then transformed into BL21 (DE3) cells.The expression of IP-IO fusion protein was induced with IPTG and purified using the Ni2+ affinity chromatography. The bioaetivity of IP-10 fusion protein was detected by transwell migration assay. [ Results ] The constructed recombinant plasmid pET-32a (+)- IP10 was correct, which was identified by DNA sequencing. The relative molecular mass (Mr) of the expressed prod- ucts was 37 000 with expected molecular weight. The satisfactory chemotactic activity of IP-10 was detected by transwell migration assay on activated T cells. [ Conclusion ] The fusion protein of pET-32a(+)-IP10 with bioactivity is expressed successfully in E. coli.
出处
《中国现代医学杂志》
CAS
CSCD
北大核心
2009年第23期3521-3524,3528,共5页
China Journal of Modern Medicine
基金
国家自然科学基金(No:30470613)
教育部博士点专项基金(No:20040610053)